Corrigendum to ‘Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression’ [Journal of Neuroimmunology, 233 (2011) 221–227]
نویسندگان
چکیده
منابع مشابه
Immunoprotection against toxic biomarkers is retained during Parkinson's disease progression.
The aim was to ascertain any possible linkage between humoral immune responses to principal biomarkers (α-synuclein monomers, its toxic oligomers or fibrils, dopamine and S100B) and cellular immunity in Parkinson's disease development. There were elevated autoantibody titers to α-synuclein monomers, oligomers plus fibrils in 72%, 56%, and 17% of Parkinsonian patients respectively with a 5-year ...
متن کاملJournal of Neuroimmunology
Bauer, J., U. Ganter, et al. (1993). "Effects of interleukin-1 and interleukin-6 on metallothionein and amyloid precursor protein expression in human neuroblastoma cells: Evidence that interleukin-6 possibly acts via a receptor different from the 80-kDa interleukin-6 receptor." Journal of Neuroimmunology 45(1-2): 163. http://www.sciencedirect.com/science/article/B6T03-476WCFHWM/2/9f385781b125e3...
متن کاملBiomarkers of HIV Susceptibility and Disease Progression☆
a Department of Microbiology and Immunology, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19102, United States b Center forMolecular Virology and Translational Neuroscience, Institute forMolecularMedicine and InfectiousDisease, Drexel University College ofMedicine, Philadelphia, PA 19102, United States c Center for Genomic Scie...
متن کاملRab11 in Disease Progression
Membrane/ protein trafficking in the secretory/ biosynthetic and endocytic pathways is mediated by vesicles. Vesicle trafficking in eukaryotes is regulated by a class of small monomeric GTPases the Rab protein family. Rab proteins represent the largest branch of the Ras superfamily GTPases, and have been concerned in a variety of intracellular vesicle trafficking and different intracellular sig...
متن کاملMonitoring clinical progression with mitochondrial disease biomarkers
Mitochondrial disorders are genetically determined metabolic diseases due to a biochemical deficiency of the respiratory chain. Given that multi-system involvement and disease progression are common features of mitochondrial disorders they carry substantial morbidity and mortality. Despite this, no disease-modifying treatments exist with clear clinical benefits, and the current best management ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neuroimmunology
سال: 2014
ISSN: 0165-5728
DOI: 10.1016/j.jneuroim.2014.01.001